Tapewire

Nasdaq · USD

OM

Outset Medical, Inc.

Export transactions ↓
Tapewire entity
7026
SEC CIK
0001484612
Parsed reports
379

Last 12 months

Inside the activity.

2 purchase rows · 23 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202501
Jan 202609
Feb 202603
Mar 202600
Apr 202600
May 202603
Jun 202601
Jul 202600
Aug 202603
Sep 202600
Oct 202620

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 20, 2023 Filed Mar 21, 2023 20:30 UTC
Brottem John L.General Counsel
SaleCommon Stock 2,715 $20.82 $56,526.30
Disclosure

SEC source: 0001140361-23-012810 · form4.xml · nonDerivative · entry 3

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,597

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 17, 2023.

Read SEC document
March 20, 2023 Filed Mar 21, 2023 20:30 UTC
Brottem John L.General Counsel
SaleCommon Stock 1,415 $20.82 $29,460.30
Disclosure

SEC source: 0001140361-23-012810 · form4.xml · nonDerivative · entry 2

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,312

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 17, 2023.

Read SEC document
March 20, 2023 Filed Mar 21, 2023 20:30 UTC
Brottem John L.General Counsel
Exercise / conversionCommon Stock 1,415 $9.48 $13,414.20
Disclosure

SEC source: 0001140361-23-012810 · form4.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,727

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 1,422 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c).

Read SEC document
March 01, 2023 Filed Mar 2, 2023 18:18 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionPerformance Options (right to buy) · Derivative 5,000 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-23-000027 · edgardoc.xml · derivative · entry 3

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,507

Underlying: Common Stock · 5,000 shares

Expires 2027-12-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 18:18 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 5,000 $22.33 $111,650.50
Disclosure

SEC source: 0001484612-23-000027 · edgardoc.xml · nonDerivative · entry 2

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,112

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $21.00 - $21.99 - 362 shares; $22.00 - $22.99 - 4,637 shares; $23.00 - $23.99 - 1 share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.

F3 · balance_after: Includes 608 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c).

Read SEC document
March 01, 2023 Filed Mar 2, 2023 18:18 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionCommon Stock 5,000 $3.88 $19,400.00
Disclosure

SEC source: 0001484612-23-000027 · edgardoc.xml · nonDerivative · entry 1

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,112

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 23:20 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionPerformance Options (right to buy) · Derivative 30,000 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-23-000028 · edgardoc.xml · derivative · entry 4

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,508

Underlying: Common Stock · 30,000 shares

Expires 2027-09-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 23:20 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 30,000 $22.48 $674,487.00
Disclosure

SEC source: 0001484612-23-000028 · edgardoc.xml · nonDerivative · entry 2

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 412,451

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $21.00 - $21.99 - 600 shares; $22.00 - $22.99 - 29,400 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.

F3 · balance_after: Includes 1,422 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c).

Read SEC document
March 01, 2023 Filed Mar 2, 2023 23:20 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionCommon Stock 30,000 $3.88 $116,400.00
Disclosure

SEC source: 0001484612-23-000028 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 442,451

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 01:35 UTC
Brottem John L.General Counsel
SaleCommon Stock 1,000 $24.36 $24,360.00
Disclosure

SEC source: 0001484612-23-000018 · edgardoc.xml · nonDerivative · entry 2

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,422

F2 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,953 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 01:35 UTC
Brottem John L.General Counsel
SaleCommon Stock 358 $24.36 $8,720.88
Disclosure

SEC source: 0001484612-23-000018 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,422

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 698 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 16, 2023 Filed Feb 16, 2023 20:38 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 1,667 $24.36 $40,608.12
Disclosure

SEC source: 0001484612-23-000020 · edgardoc.xml · nonDerivative · entry 2

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,504

F2 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 3,257 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 16, 2023 Filed Feb 16, 2023 20:38 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 264 $24.37 $6,433.68
Disclosure

SEC source: 0001484612-23-000020 · edgardoc.xml · nonDerivative · entry 1

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,171

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 516 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 01:45 UTC
Ahmed NabeelChief Financial Officer
SaleCommon Stock 123 $24.36 $2,996.28
Disclosure

SEC source: 0001484612-23-000024 · edgardoc.xml · nonDerivative · entry 3

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,350

F3 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 239 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 01:45 UTC
Ahmed NabeelChief Financial Officer
SaleCommon Stock 1,167 $24.36 $28,428.12
Disclosure

SEC source: 0001484612-23-000024 · edgardoc.xml · nonDerivative · entry 2

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,473

F2 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 2,280 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 01:45 UTC
Ahmed NabeelChief Financial Officer
SaleCommon Stock 269 $24.37 $6,555.53
Disclosure

SEC source: 0001484612-23-000024 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,640

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 525 shares of Common Stock underlying RSUs granted to the reporting person on August 5, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 01:43 UTC
Porter Stacey L.Chief People Officer
SaleCommon Stock 33 $24.37 $804.21
Disclosure

SEC source: 0001484612-23-000023 · edgardoc.xml · nonDerivative · entry 3

Porter Stacey L. · CIK 0001889204 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,908

F3 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 93 shares of Common Stock underlying RSUs granted to the reporting person on October 22, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 01:43 UTC
Porter Stacey L.Chief People Officer
SaleCommon Stock 112 $24.36 $2,728.32
Disclosure

SEC source: 0001484612-23-000023 · edgardoc.xml · nonDerivative · entry 2

Porter Stacey L. · CIK 0001889204 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,941

F2 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 298 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 01:43 UTC
Porter Stacey L.Chief People Officer
SaleCommon Stock 482 $24.36 $11,741.52
Disclosure

SEC source: 0001484612-23-000023 · edgardoc.xml · nonDerivative · entry 1

Porter Stacey L. · CIK 0001889204 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,053

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,384 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 01:42 UTC
Racine Jean-OlivierChief Technology Officer
SaleCommon Stock 297 $24.36 $7,234.92
Disclosure

SEC source: 0001484612-23-000022 · edgardoc.xml · nonDerivative · entry 2

Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,540

F2 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,180 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 01:42 UTC
Racine Jean-OlivierChief Technology Officer
SaleCommon Stock 451 $24.36 $10,986.36
Disclosure

SEC source: 0001484612-23-000022 · edgardoc.xml · nonDerivative · entry 1

Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,837

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,791 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 01:39 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 2,083 $24.36 $50,741.88
Disclosure

SEC source: 0001484612-23-000021 · edgardoc.xml · nonDerivative · entry 2

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 411,029

F2 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 4,071 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 01:39 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 932 $24.36 $22,703.52
Disclosure

SEC source: 0001484612-23-000021 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 413,112

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,821 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 01:36 UTC
Williamson Steven S.Chief Commercial Officer
SaleCommon Stock 694 $24.36 $16,905.84
Disclosure

SEC source: 0001484612-23-000019 · edgardoc.xml · nonDerivative · entry 1

Williamson Steven S. · CIK 0001478582 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,471

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 2,280 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 21:15 UTC
Brottem John L.General Counsel
Exercise / conversionPerformance Options (right to buy) · Derivative 2,265 $0.00 Strike: $9.48 $0.00
Disclosure

SEC source: 0001484612-23-000025 · edgardoc.xml · derivative · entry 7

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,265 shares

Expires 2030-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 21:15 UTC
Brottem John L.General Counsel
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,829 $0.00 Strike: $9.48 $0.00
Disclosure

SEC source: 0001484612-23-000025 · edgardoc.xml · derivative · entry 6

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,633

Underlying: Common Stock · 2,829 shares

Expires 2030-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 21:15 UTC
Brottem John L.General Counsel
SaleCommon Stock 3,532 $24.22 $85,545.04
Disclosure

SEC source: 0001484612-23-000025 · edgardoc.xml · nonDerivative · entry 5

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,890

Read SEC document
February 16, 2023 Filed Feb 17, 2023 21:15 UTC
Brottem John L.General Counsel
SaleCommon Stock 2,829 $23.96 $67,770.39
Disclosure

SEC source: 0001484612-23-000025 · edgardoc.xml · nonDerivative · entry 4

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,422

F1 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $23.00-$23.99 - 3,486 shares; $24.00-$24.99 - 1,608 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 21:15 UTC
Brottem John L.General Counsel
Exercise / conversionCommon Stock 2,829 $9.48 $26,818.92
Disclosure

SEC source: 0001484612-23-000025 · edgardoc.xml · nonDerivative · entry 3

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,251

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 21:15 UTC
Brottem John L.General Counsel
SaleCommon Stock 2,265 $23.96 $54,259.43
Disclosure

SEC source: 0001484612-23-000025 · edgardoc.xml · nonDerivative · entry 2

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,422

F1 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $23.00-$23.99 - 3,486 shares; $24.00-$24.99 - 1,608 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 21:15 UTC
Brottem John L.General Counsel
Exercise / conversionCommon Stock 2,265 $9.48 $21,472.20
Disclosure

SEC source: 0001484612-23-000025 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,687

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 02, 2023 Filed Mar 2, 2023 18:15 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionPerformance Options (right to buy) · Derivative 6,500 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-23-000026 · edgardoc.xml · derivative · entry 12

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,507

Underlying: Common Stock · 6,500 shares

Expires 2027-12-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
February 02, 2023 Filed Mar 2, 2023 18:15 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionPerformance Options (right to buy) · Derivative 6,500 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-23-000026 · edgardoc.xml · derivative · entry 11

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,007

Underlying: Common Stock · 6,500 shares

Expires 2027-12-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
February 02, 2023 Filed Mar 2, 2023 18:15 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionPerformance Options (right to buy) · Derivative 6,500 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-23-000026 · edgardoc.xml · derivative · entry 10

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,507

Underlying: Common Stock · 6,500 shares

Expires 2027-12-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
February 02, 2023 Filed Mar 2, 2023 18:15 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 6,500 $30.00 $195,000.00
Disclosure

SEC source: 0001484612-23-000026 · edgardoc.xml · nonDerivative · entry 8

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,435

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.

Read SEC document
February 02, 2023 Filed Mar 2, 2023 18:15 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionCommon Stock 6,500 $3.88 $25,220.00
Disclosure

SEC source: 0001484612-23-000026 · edgardoc.xml · nonDerivative · entry 7

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,935

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 02, 2023 Filed Mar 2, 2023 18:15 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 6,500 $30.00 $195,000.00
Disclosure

SEC source: 0001484612-23-000026 · edgardoc.xml · nonDerivative · entry 6

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,435

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.

Read SEC document
February 02, 2023 Filed Mar 2, 2023 18:15 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionCommon Stock 6,500 $3.88 $25,220.00
Disclosure

SEC source: 0001484612-23-000026 · edgardoc.xml · nonDerivative · entry 5

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,935

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 02, 2023 Filed Mar 2, 2023 18:15 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 6,500 $30.00 $195,000.00
Disclosure

SEC source: 0001484612-23-000026 · edgardoc.xml · nonDerivative · entry 4

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,435

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.

Read SEC document
February 02, 2023 Filed Mar 2, 2023 18:15 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionCommon Stock 6,500 $3.88 $25,220.00
Disclosure

SEC source: 0001484612-23-000026 · edgardoc.xml · nonDerivative · entry 3

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,935

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2023 Filed Feb 2, 2023 23:41 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionPerformance Options (right to buy) · Derivative 30,000 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-23-000017 · edgardoc.xml · derivative · entry 4

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,508

Underlying: Common Stock · 30,000 shares

Expires 2027-09-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
February 01, 2023 Filed Feb 2, 2023 23:41 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 30,000 $28.06 $841,779.00
Disclosure

SEC source: 0001484612-23-000017 · edgardoc.xml · nonDerivative · entry 2

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 414,044

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $27.00 - $27.99 - 14,718 shares; $28.00 - $28.99 - 15,282 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.

Read SEC document
February 01, 2023 Filed Feb 2, 2023 23:41 UTC
Trigg LeslieDirector · Chair and CEO
Exercise / conversionCommon Stock 30,000 $3.88 $116,400.00
Disclosure

SEC source: 0001484612-23-000017 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 444,044

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 01, 2023 Filed Mar 2, 2023 18:15 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionPerformance Options (right to buy) · Derivative 5,000 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001484612-23-000026 · edgardoc.xml · derivative · entry 9

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,007

Underlying: Common Stock · 5,000 shares

Expires 2027-12-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.

Read SEC document
February 01, 2023 Filed Mar 2, 2023 18:15 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 5,000 $27.91 $139,553.50
Disclosure

SEC source: 0001484612-23-000026 · edgardoc.xml · nonDerivative · entry 2

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,435

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $27.00 - $27.99 - 3,640 shares; $28.00 - $28.99 - 1,360 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.

Read SEC document
February 01, 2023 Filed Mar 2, 2023 18:15 UTC
Vazquez MartinChief Operating Officer
Exercise / conversionCommon Stock 5,000 $3.88 $19,400.00
Disclosure

SEC source: 0001484612-23-000026 · edgardoc.xml · nonDerivative · entry 1

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,435

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 27, 2023 Filed Jan 30, 2023 21:42 UTC
Brottem John L.General Counsel
SaleCommon Stock 4,282 $27.92 $119,553.44
Disclosure

SEC source: 0001484612-23-000011 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,780

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 7,814 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
January 27, 2023 Filed Jan 30, 2023 16:47 UTC
Vazquez MartinChief Operating Officer
SaleCommon Stock 4,674 $27.92 $130,498.08
Disclosure

SEC source: 0001484612-23-000015 · edgardoc.xml · nonDerivative · entry 1

Vazquez Martin · CIK 0001823380 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,435

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 13,023 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
January 27, 2023 Filed Jan 30, 2023 21:47 UTC
Williamson Steven S.Chief Commercial Officer
SaleCommon Stock 3,023 $27.92 $84,402.16
Disclosure

SEC source: 0001484612-23-000016 · edgardoc.xml · nonDerivative · entry 1

Williamson Steven S. · CIK 0001478582 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,165

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 9,116 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
January 27, 2023 Filed Jan 30, 2023 21:46 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 6,281 $27.92 $175,365.52
Disclosure

SEC source: 0001484612-23-000014 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 414,044

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 16,278 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.